Future Of Vitamin D In Cancer: Where Are We Today?
Main Article Content
Abstract
Vitamin D, an essential nutrient, is a precursor of a potent steroid hormone that regulates a broad spectrum of physiological processes. Vitamin D sufficiency is accessory with protection against malignancy in a number of tissues clinically, and a powerful body of evidence from animal and cell culture studies supports this protective role [22]. Numerous epidemiological, preclinical and cellular researches have revealed that vitamin D levels have an inverse relation with cancer mortality, while others have considered it a inherent risk factor [74]. There is increasing evidence linking the incidence and prognosis of certain cancers to low serum25 (OH) D3 levels. This article is a descriptive review of recent epidemiological findings regarding, serum 25-hydroxyvitamin D [25(OH)D]
concentrations, vitamin D supplementation, and genetic variations in 25(OH)D concentration for incidence, progression, survival, and mortality rates of overall and breast, lung, colorectal, and Prostatic adenocarcinoma which include geographical ecological studies, observational studies associated with oral vitamin D intake and serum 25-Hydroxyl vitamin D [25(OH)D] concentrations, randomized Controlled trials (RCTs) of cholecalciferol supplementation, studies of genetic allele polymorphisms affecting 25(OH)D concentrations and mechanisms [75].Thus, all kinds of studies should be considered when assessing how vitamin D affects cancer.
Therefore, using large observational claims, database, with real world unstructured treatment patterns, we qualitatively reviewed the epidemiological evidence within the oncology literature on the association between usage of vitamin D supplement and minimization of cancer risk with suggestions on how the evidence may be strengthened
References
Yang J, et al: Serum25-hydroxyvitamin and risk of cancer in a large community population under investigation for cardiovascular disease: a retrospective cohort study. BMJ Open 2022;12: e056543.
Wong et al: Vitamin D and cancer mortality. BMC Cancer (2015) 15:106.
William B. Grant and Alan N. Peiris: Differences in vitamin D may account for unexplained disparities in cancer survival rates b/w African and white Americans. Dermato-Endocrinology 4:2, 85–94; April/May/June 2012.
Dev, Del Fabbro, Schwartz et al: Preliminary report: Vitamin D Deficiency in Advanced Cancer Patients with Symptoms of Fatigue or Anorexia. The Oncologist 2011; 16:1637–1641.
Yin et al: Independent and joint associations between serum calcium, 25-hydroxy vitamin D and the risk of primary liver cancer. Cancer Epidemiol Biomarkers Prev. 2020; 29(10):2057–2064.
Xia Jiang et al: Circulating vitamin D concentrations and risk of breast and prostate cancer. International Journal of Epidemiology, 2019.
Aytekin: Comparison of Vitamin D Levels in Cancer Patients b/w healthy individuals and cancer patients.
Grant WB, Boucher BJ: Randomized controlled trials of vitamin D and cancer incidence: A modeling study. PLoS ONE 12(5): e0176448.
Ayla Acikgoz et al: Effect of serum 25-hydroxyvitamin D level on lung, breast, colorectal and prostate cancers. EMHJ 2020.
Meyer et al: Dietary Vitamin D Intake and Serum 25-Hydroxyvitamin D Level in Relation to Disease Outcomes in Head and Neck Cancer Patients. Int J Cancer 2011;128(7):1741–1746.
Robsahm et al: Serum 25-hydroxyvitamin D levels predict cancer survival. Clinical Epidemiology 2019.
Luo et al: 24-Hydroxylase in Cancer: Impact on Vitamin D-based Anticancer Therapeutics. J Steroid Biochem Mol Biol. 2013.
J-B Wang et al: Association between serum 25(OH) vitamin D, incident liver cancer and chronic liver disease mortality.
Jung Hyun Kwak and Jean Kyung Paik: Vitamin D Status and Gastric Cancer. Nutrients 2020.
Yilmaz et al: Pediatric brain tumors and VDR polymorphism.
Madden et al: Causal Models for Vitamin D and Breast Cancer. Am J Epidemiol. 2020.
Meeker S et al: Vitamin D, IBD and colon cancer. World J Gastroenterol 2016.
Wagner et al: Clinical Trial of Vitamin D in Prostate Cancer.
Marcus Stanaland et al: Serum Vitamin D Levels in Prostate Cancer.
Weinstein et al: Serum 25-hydroxyvitamin D and colorectal cancer risk.
Mondul et al: Serum vitamin D and bladder cancer risk.
Bikle et al: Protective Role of Vitamin D in Skin Cancer.
Vashi et al: Serum vitamin D and BMI in cancer.
Kratzer et al: Vitamin D Binding Protein and renal cell carcinoma risk.
Vojdeman et al: Vitamin D levels and cancer incidence in Denmark.
Isenring et al: Serum vitamin D decreases during chemotherapy.
Garland et al: Vitamin D doses and cancer prevention.
Piper et al: Vitamin D binding protein and pancreatic cancer.
D-Y Shin et al: Serum vitamin D and EGFR mutation in lung cancer.
Hoffer et al: Vitamin D loading regimen for lung cancer.
Wei et al: Vitamin D and lung cancer risk meta-analysis.
Feng et al: Vitamin D and lung cancer survival meta-analysis.
Kim et al: Vitamin D receptor in lung adenocarcinoma.
Alissa R et al: Vitamin D suppresses lung cancer growth.
Haznadar et al: Vitamin D SNPs and lung cancer.
Li et al: Lung diseases and vitamin D deficiency.
McFarland et al: Vitamin D deficiency and lung cancer prognosis.
Gromowski et al: Vitamin D gene variants and lung cancer.
Weinstein et al: Vitamin D and lung cancer risk.
Cheng et al: Vitamin D and lung cancer in non-smokers.
Sun et al: Vitamin D and lung cancer risk (Mendelian study).
Anic et al: Vitamin D and lung cancer survival.
Akiba et al: RCT of Vitamin D for lung cancer.
Tatiana Shaurova et al: Vitamin D metabolites and lung cancer prognosis.
Wesselink et al: Vitamin D levels during chemotherapy (CRC).
Peyman Ranji et al: Probiotics, vitamin D and colon cancer.
Giovanni: Vitamin D and colorectal cancer epidemiology.
Baron et al: Vitamin D and colorectal adenomas trial.
Uzma Shamsi et al: Vitamin D and breast cancer (Pakistan).
Chartron et al: High-dose Vitamin D in breast cancer.
Narjust Duma et al: Vitamin D and breast density.
Shaukat et al: Vitamin D deficiency and breast cancer.
Wahler et al: Vitamin D and breast cancer stem cells.
Abdelgawad et al: Vitamin D levels in breast cancer patients.
Radom A: Factors affecting vitamin D in breast cancer.
JoEllen Welsh: Vitamin D endocrine system in breast cancer.
Tokunaga et al: Vitamin D and chemotherapy response.
Abeer Ismail et al: Vitamin D levels in Egyptian breast cancer patients.
Crew et al: Vitamin D supplementation trial (breast cancer).
Husain et al: Vitamin D and breast cancer in Sudan.
Chiba et al: Vitamin D and treatment response in breast cancer.
O’Brien et al: Vitamin D and breast cancer risk.
O’Brien et al: Vitamin D gene polymorphisms and breast cancer.
Obaidi et al: Vitamin D and breast cancer (evidence-based).
Imtiaz et al: Vitamin D deficiency in breast cancer.
Gul Alco et al: Vitamin D levels and dressing style.
Michael B et al: Vitamin D in breast cancer survivors.
Tavera-Mendoza et al: Vitamin D receptor and breast cancer.
Yousef et al: Vitamin D status in Saudi women (breast cancer).
Going et al: Vitamin D and cholesterol in breast cancer.
O’Brien et al: Vitamin D and DNA methylation in breast cancer.
Jeon and Shin: Vitamin D metabolism in cancer.
Nikolac Gabaj N et al: Vitamin D in health and disease.
Gupta et al: Vitamin D deficiency and cancer.
Grant: Vitamin D in reducing cancer risk.
Martin-Gorgojo et al: Vitamin D and skin cancer.
Rozmus D et al: Vitamin D binding protein and tumors.
Buttigliero et al: Vitamin D and cancer prognosis review.
Jian Liu et al: Vitamin D and lung cancer meta-analysis.
Liqun Zhang et al: Vitamin D and lung cancer review.
Ekmekcioglu C et al: Vitamin D and colorectal cancer risk.
Guiyun Zhou et al: Optimizing vitamin D to reduce cancer risk.
Tommie et al: Vitamin D and breast cancer risk review.
Atoum and Alzgoulool: Vitamin D and breast cancer future steps.
Voutsadakis A et al: Vitamin D levels at breast cancer diagnosis.
Sharif B Mohr: History of vitamin D and cancer prevention.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.